Affymetrix (Nasdaq: AFFX) reported earnings on July 31. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), Affymetrix met expectations on revenues and exceeded expectations on earnings per share.

Compared to the prior-year quarter, revenue increased slightly and GAAP earnings per share expanded.

Gross margins shrank, operating margins dropped, net margins increased.

Revenue details
Affymetrix logged revenue of $66.4 million. The 13 analysts polled by S&P Capital IQ looked for revenue of $67.1 million on the same basis. GAAP reported sales were 2.7% higher than the prior-year quarter's $64.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at -$0.02. The 15 earnings estimates compiled by S&P Capital IQ forecast -$0.08 per share. GAAP EPS were $0.43 for Q2 compared to -$0.05 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 58.3%, 180 basis points worse than the prior-year quarter. Operating margin was -23.2%, 1,840 basis points worse than the prior-year quarter. Net margin was 46.5%, 5,220 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $85.7 million. On the bottom line, the average EPS estimate is -$0.03.

Next year's average estimate for revenue is $308.8 million. The average EPS estimate is -$0.18.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 348 members out of 411 rating the stock outperform, and 63 members rating it underperform. Among 100 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 88 give Affymetrix a green thumbs-up, and 12 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Affymetrix is hold, with an average price target of $5.38.

Over the decades, small-cap stocks like Affymetrix have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.